European shares finished marginally higher on Monday, supported by defence stocks, while Novo Nordisk gained after data showed its weight-loss drug Wegovy delivers stronger heart-protective benefits than Eli Lilly's rival therapies.
The pan-European STOXX 600 closed up 0.17% at 551.07, with gains led by the aerospace and defence index, which surged 2.1% to hover near a record high.
Defence giants, Rolls-Royce Holdings, Rheinmetall and Hensoldt advanced between 2.8% and 4.5%.
Gains followed a Financial Times report that European Commission President Ursula von der Leyen said Europe was preparing "pretty precise plans" to send troops to Ukraine as part of post-conflict security guarantees.
Britain's BAE Systems was up 1.8%, as Norway said it had chosen Britain for the acquisition of new frigates, in a deal worth some 10 billion pounds ($13.51 billion).
Danish drugmaker Novo Nordisk, the fourth-largest healthcare company on the STOXX index, rose 1.8% after the company said Wegovy cut the risk of heart attack, stroke or death by 57% versus Eli Lilly's rival medicines Mounjaro and Zepbound in a real-world comparison.
The stock bolstered the healthcare index, rising 0.27%. Denmark's main stock index gained 1.1%, also aided by Novo's domestic peer Zealand Pharma that ended 3.5% higher.
Overall gains were limited by a jump in long-dated euro zone bond yields on persistent worries about government debt levels around the world.
Source : Reuters
European bourses opened September in positive territory, with both the STOXX 50 and STOXX 600 rising nearly 0.3% after modest gains in August. Trading is expected to remain subdued today, as US market...
Asia-Pacific markets traded mixed Monday as investors assess China's RatingDog manufacturing data for August. The metric - which was previously known as the Caixin Purchasing Managers' Index - came in...
US stocks fell in the afternoon trading as investors took profits following a strong week that saw the S&P 500 reach record highs, amid signs that inflationary pressures remain persistent in the U...
US stocks pulled back on Friday as the latest economic data continued to reflect stubborn inflationary pressures in the US economy, clouding the Fed's rate outlook. The S&P 500 and the Dow droppe...
European stock markets are heading for a mixed open on Friday as attention turns to inflation prints from some of the region's biggest economies, along with the U.S. Price rise data is due from Franc...
Silver (XAG/USD) kicks off the week on a strong footing, with spot prices extending their rally for a fifth consecutive session, breaking above the $40.00 mark to hit fresh 14-year highs — levels last seen in September 2011. At the time of writing,...
European shares finished marginally higher on Monday, supported by defence stocks, while Novo Nordisk gained after data showed its weight-loss drug Wegovy delivers stronger heart-protective benefits than Eli Lilly's rival therapies. The...
Gold (XAU/USD) started the week on a stronger note, extending its five-day rally to reach its highest level in more than four months, last seen on April 22. A generally weaker US dollar and strong expectations for a Federal Reserve (Fed) interest...
A U.S. appeals court ruled on Friday that most of President Donald Trump's global tariffs were illegal, finding he exceeded his authority when...
Indonesia's central bank will remain active in the foreign exchange market to stabilise the rupiah, it said on Friday, while the stock exchange...
European bourses opened September in positive territory, with both the STOXX 50 and STOXX 600 rising nearly 0.3% after modest gains in August....
Asia-Pacific markets traded mixed Monday as investors assess China's RatingDog manufacturing data for August. The metric - which was previously...